Literature DB >> 18608687

Impairments in fine-motor coordination and speed of information processing predict declines in everyday functioning in hepatitis C infection.

Ofilio Vigil1, Carolina Posada, Steven Paul Woods, J Hampton Atkinson, Robert K Heaton, William Perry, Tarek I Hassanein, Igor Grant, Scott L Letendre.   

Abstract

Research increasingly supports the neurovirulence of chronic infection with the hepatitis C virus (HCV). For example, HCV infection has been associated with neuropsychological impairment in several ability areas, including psychomotor skills. This study aimed to examine whether HCV-associated neuropsychological impairment is predictive of declines in the independent performance of physical (PADLs) and instrumental (IADLs) activities of daily living. A total of 106 volunteers with HCV infection completed a comprehensive neuropsychological, medical, and psychiatric research evaluation. As compared to 30 HCV-seronegative comparison participants, the HCV-infected group reported significantly greater declines in both PADLs and IADLs. Within the HCV cohort, individuals with impaired speed of information processing reported significantly greater IADL declines, whereas impaired fine-motor coordination was associated with declines in both IADLs and PADLs. In a series of regression analyses, impaired speed of information processing and depressive symptoms (as measured by the Beck Depression Inventory) were the only independent predictors of IADL declines, whereas general affective distress (as measured by the Profile of Mood States), sex, and fine-motor coordination impairment were predictive of declines in PADLs. Although the clinical assessment of HCV typically emphasizes both affective (e.g., depression) and physical factors, findings from the present study suggest that cognitive impairment is an important contributor to everyday functioning in persons living with HCV infection and therefore warrants consideration in clinical and research evaluations.

Entities:  

Mesh:

Year:  2008        PMID: 18608687      PMCID: PMC2837785          DOI: 10.1080/13803390701802354

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  34 in total

1.  Diagnosis, management, and treatment of hepatitis C.

Authors:  Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

2.  Paced auditory serial-addition task: a measure of recovery from concussion.

Authors:  D M Gronwall
Journal:  Percept Mot Skills       Date:  1977-04

3.  Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease.

Authors:  Daniel M Forton; Howard C Thomas; Christine A Murphy; Joanna M Allsop; Graham R Foster; Janice Main; Keith A Wesnes; Simon D Taylor-Robinson
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

Review 4.  A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection.

Authors:  Daniel M Forton; Joanna M Allsop; I Jane Cox; Gavin Hamilton; Keith Wesnes; Howard C Thomas; Simon D Taylor-Robinson
Journal:  AIDS       Date:  2005-10       Impact factor: 4.177

5.  Hepatitis C virus infection and neurocognitive function.

Authors:  M Soogoor; H S Lynn; S M Donfield; E Gomperts; T S Bell; E S Daar
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

6.  Action (verb) fluency predicts dependence in instrumental activities of daily living in persons infected with HIV-1.

Authors:  Steven Paul Woods; Erin E Morgan; Matthew Dawson; J Cobb Scott; Igor Grant
Journal:  J Clin Exp Neuropsychol       Date:  2006-08       Impact factor: 2.475

7.  Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C.

Authors:  K B Hussain; R J Fontana; C A Moyer; G L Su; N Sneed-Pee; A S Lok
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

8.  Differential contributions of cognitive and motor component processes to physical and instrumental activities of daily living in Parkinson's disease.

Authors:  D A Cahn; E V Sullivan; P K Shear; A Pfefferbaum; G Heit; G Silverberg
Journal:  Arch Clin Neuropsychol       Date:  1998-10       Impact factor: 2.813

9.  HIV-associated prospective memory impairment increases risk of dependence in everyday functioning.

Authors:  Steven Paul Woods; Jennifer E Iudicello; Lisa M Moran; Catherine L Carey; Matthew S Dawson; Igor Grant
Journal:  Neuropsychology       Date:  2008-01       Impact factor: 3.295

10.  Cognitive reserve and neuropsychological functioning in patients infected with hepatitis C.

Authors:  Linas A Bieliauskas; Carla Back-Madruga; Karen L Lindsay; Elizabeth C Wright; Ziad Kronfol; Anna S F Lok; Robert J Fontana
Journal:  J Int Neuropsychol Soc       Date:  2007-05-18       Impact factor: 2.892

View more
  16 in total

1.  Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.

Authors:  David J Moore; Kaitlin Blackstone; Steven Paul Woods; Ronald J Ellis; J Hampton Atkinson; Robert K Heaton; Igor Grant
Journal:  AIDS Care       Date:  2012-04-24

2.  Intra-individual variability across neurocognitive domains in chronic hepatitis C infection: elevated dispersion is associated with serostatus and unemployment risk.

Authors:  Erin E Morgan; Steven Paul Woods; Alexandra Rooney; William Perry; Igor Grant; Scott L Letendre
Journal:  Clin Neuropsychol       Date:  2012-04-26       Impact factor: 3.535

3.  Protective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis C.

Authors:  Maiko Sakamoto; Steven Paul Woods; Michael Kolessar; Daniel Kriz; J Renee Anderson; Hannah Olavarria; Anna W Sasaki; Michael Chang; Kenneth D Flora; Jennifer M Loftis; Marilyn Huckans
Journal:  J Neurovirol       Date:  2013-09-10       Impact factor: 2.643

4.  Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV.

Authors:  Stephanie Chiao; Howard J Rosen; Krista Nicolas; Lauren A Wendelken; Oscar Alcantar; Katherine P Rankin; Bruce Miller; Victor Valcour
Journal:  AIDS Res Hum Retroviruses       Date:  2013-03-20       Impact factor: 2.205

5.  Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND.

Authors:  Lisa C Obermeit; Jessica Beltran; Kaitlin B Casaletto; Donald R Franklin; Scott Letendre; Ronald Ellis; Christine Fennema-Notestine; Florin Vaida; Ann C Collier; Christina M Marra; David Clifford; Benjamin Gelman; Ned Sacktor; Susan Morgello; David Simpson; J Allen McCutchan; Igor Grant; Robert K Heaton
Journal:  J Neurovirol       Date:  2016-08-24       Impact factor: 2.643

6.  Intra-individual neurocognitive variability confers risk of dependence in activities of daily living among HIV-seropositive individuals without HIV-associated neurocognitive disorders.

Authors:  Erin E Morgan; Steven Paul Woods; Igor Grant
Journal:  Arch Clin Neuropsychol       Date:  2012-02-15       Impact factor: 2.813

7.  Implications of hepatitis C virus infection for behavioral symptoms and activities of daily living.

Authors:  Carolina Posada; David J Moore; Steven Paul Woods; Ofilio Vigil; Chris Ake; William Perry; Tarek I Hassanein; Scott L Letendre; Igor Grant
Journal:  J Clin Exp Neuropsychol       Date:  2010-07       Impact factor: 2.475

8.  Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C.

Authors:  Victor G Valcour; Leah H Rubin; Mary U Obasi; Pauline M Maki; Marion G Peters; Susanna Levin; Howard A Crystal; Mary A Young; Wendy J Mack; Mardge H Cohen; Christopher B Pierce; Adaora A Adimora; Phyllis C Tien
Journal:  J Acquir Immune Defic Syndr       Date:  2016-07-01       Impact factor: 3.731

9.  Brain Microstructural Correlates of Cognitive Dysfunction in Clinically and Biochemically Normal Hepatitis C Virus Infection.

Authors:  Ajay Kumar; Amar Deep; Rakesh K Gupta; Virendra Atam; Samir Mohindra
Journal:  J Clin Exp Hepatol       Date:  2017-04-04

10.  Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use.

Authors:  Kaitlin Blackstone; Jennifer E Iudicello; Erin E Morgan; Erica Weber; David J Moore; Donald R Franklin; Ronald J Ellis; Igor Grant; Steven Paul Woods
Journal:  J Addict Med       Date:  2013 Jul-Aug       Impact factor: 3.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.